companydata.dkcompanydata.dk

GILEAD SCIENCES DENMARK ApS: Financial statements 2023

CVR: 30899032

Source: annual report 2023, Danish Business Authority

01/01/202331/12/2023

GILEAD SCIENCES DENMARK ApS (CVR 30899032) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 109,907,440 and a net result of DKK 3,207,507 compared with DKK 5,284,332 the year before. That is a decrease of 51.9% compared with the year before. The profit margin was 2.9%. Equity in the 2023 report amounted to DKK 54,127,920. The solvency ratio was 63.7%. The company had 13 employees in the financial year.

Revenue
DKK 109,907,440
Gross Profit
DKK 22,697,854
Profit/Loss
DKK 3,207,507
Equity
DKK 54,127,920
Total Assets
DKK 85,028,209
Employees
13

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023109.9 mio.22.7 mio.3.2 mio.54.1 mio.13
2022228.4 mio.27.5 mio.5.3 mio.50.9 mio.12
2021174.8 mio.28 mio.3.9 mio.45.6 mio.13
2020150.7 mio.28 mio.3.8 mio.41.7 mio.13
2019-22.6 mio.2.8 mio.38 mio.12

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

GILEAD SCIENCES DENMARK ApS: The 2022 annual report is outMay 30, 2023

GILEAD SCIENCES DENMARK ApS has published its annual report for 2022. Revenue came to DKK 228,372,476, and the net result was DKK 5,284,332.

Hans York-Julian Stücker joins the board of GILEAD SCIENCES DENMARK ApSApr 6, 2023

As of April 6, 2023, Hans York-Julian Stücker has joined the board of directors of GILEAD SCIENCES DENMARK ApS.

John Andrew Jorden joins the board of GILEAD SCIENCES DENMARK ApSApr 6, 2023

As of April 6, 2023, John Andrew Jorden has joined the board of directors of GILEAD SCIENCES DENMARK ApS.

Janet Elizabeth Dorling joins the board of GILEAD SCIENCES DENMARK ApSApr 6, 2023

As of April 6, 2023, Janet Elizabeth Dorling has joined the board of directors of GILEAD SCIENCES DENMARK ApS.

Rudolf Ertl leaves the board of GILEAD SCIENCES DENMARK ApSApr 6, 2023

As of April 6, 2023, Rudolf Ertl has left the board of directors of GILEAD SCIENCES DENMARK ApS.

Pawel Trawkowski leaves the board of GILEAD SCIENCES DENMARK ApSApr 6, 2023

As of April 6, 2023, Pawel Trawkowski has left the board of directors of GILEAD SCIENCES DENMARK ApS.

Hans York-Julian Stücker leaves the board of GILEAD SCIENCES DENMARK ApSApr 5, 2023

As of April 5, 2023, Hans York-Julian Stücker has left the board of directors of GILEAD SCIENCES DENMARK ApS.

About GILEAD SCIENCES DENMARK ApS

GILEAD SCIENCES DENMARK ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2007. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The management consists of Pau Arbos Vila, Anna Sophia Melén and Helene Annika Oscarsson. The board consists of Hans York-Julian Stücker (chair), Josephine Yang Comiskey and Juan Peche Marín-Lázaro. The company is owned by Gilead Sciences Ireland UC. The company has 11 employees (2018). In 2025, the company reported revenue of DKK 186,763,801 and a net result of DKK 5,145,834 compared with DKK 5,860,294 the year before. Equity in the 2025 report amounted to DKK 65,134,048.

Source: annual report 2025, Danish Business Authority